Stock BUDZ WEED, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials WEED, Inc.

Equities

BUDZ

US9485081064

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 03:55:07 2024-05-03 pm EDT 		5-day change 1st Jan Change
0.0821 USD +0.07% Intraday chart for WEED, Inc. +2.62% +12.47%
Apr. 01 WEED, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 WEED, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 110.6 34.54 24.94 31 10.5 9.014
Enterprise Value (EV) 1 110.2 34.84 25.09 31.64 10.93 8.892
P/E ratio -3.7 x -1.25 x -6.07 x -10.7 x -6.79 x -286 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -3.95 x -1.28 x -6.38 x -11.8 x -7.5 x -12.4 x
EV / FCF 16.3 x 4.09 x 20.9 x 151 x -39.8 x -14.9 x
FCF Yield 6.14% 24.4% 4.78% 0.66% -2.52% -6.7%
Price to Book 40.3 x 29 x 28.3 x 50.2 x 61.8 x 35.3 x
Nbr of stocks (in thousands) 105,361 108,323 113,373 119,223 123,483 123,483
Reference price 2 1.050 0.3189 0.2200 0.2600 0.0850 0.0730
Announcement Date 4/16/19 3/30/20 3/31/21 3/31/22 3/31/23 4/1/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA 1 -27.9 -27.26 -3.931 -2.672 -1.458 -0.7182
EBIT 1 -28.08 -27.42 -4.076 -2.801 -1.569 -0.7706
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -29.32 -27.53 -4.065 -2.842 -1.528 -0.0306
Net income 1 -29.32 -27.53 -4.065 -2.842 -1.528 -0.0316
Net margin - - - - - -
EPS 2 -0.2841 -0.2557 -0.0362 -0.0243 -0.0125 -0.000255
Free Cash Flow 1 6.772 8.516 1.199 0.2101 -0.2751 -0.5956
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/16/19 3/30/20 3/31/21 3/31/22 3/31/23 4/1/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.3 0.15 0.64 0.44 -
Net Cash position 1 0.41 - - - - 0.12
Leverage (Debt/EBITDA) - -0.0109 x -0.0378 x -0.2404 x -0.3008 x -
Free Cash Flow 1 6.77 8.52 1.2 0.21 -0.28 -0.6
ROE (net income / shareholders' equity) -1,878% -1,390% -391% -379% -388% -14.8%
ROA (Net income/ Total Assets) -811% -689% -135% -92.7% -54.6% -38%
Assets 1 3.615 3.995 3.009 3.066 2.799 0.0831
Book Value Per Share 2 0.0300 0.0100 0.0100 0.0100 0 0
Cash Flow per Share 2 0 0 0 0 0 0
Capex 1 0.83 0 - 0.27 - 0.01
Capex / Sales - - - - - -
Announcement Date 4/16/19 3/30/20 3/31/21 3/31/22 3/31/23 4/1/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
WEED, INC. Stock WEED, Inc.
+12.47% 10.13M
MODERNA, INC. Stock Moderna, Inc.
+25.69% 47.86B
LONZA GROUP AG Stock Lonza Group AG
+46.90% 41.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-3.46% 40.66B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.92B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+9.17% 25.55B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.42% 19.27B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.17% 12.15B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.07% 12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.24% 11.99B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. BUDZ Stock
  4. Financials WEED, Inc.